{
    "clinical_study": {
        "@rank": "55450", 
        "arm_group": [
            {
                "arm_group_label": "ALS patients receivng stem cells", 
                "arm_group_type": "Active Comparator", 
                "description": "Amyotrophic lateral sclerosis(ALS)subjects, who will be receiving stem cells,  will undergo a brief clinical evaluation and questionnaire that will last approximately 20 to 30 min. Subjects will be asked to undergo magnetic resonance imaging(MRI)scans of the cervical spine and brain that will last approximately 60 minutes."
            }, 
            {
                "arm_group_label": "ALS patients not receiving stem cells", 
                "arm_group_type": "Active Comparator", 
                "description": "Amyotrophic lateral sclerosis(ALS)patient who will not be receiving stem cells,  will have an MRI that lasts approximately 60 minutes.  This MRI will be repeated at three different time points.  Subjects will have an initial MRI, then another at both 6 and 12 months after the initial magnetic resonance imaging(MRI)scan.  Subjects will also complete a clinical examination which will take approximately 30 minutes for each MRI.  The follow-up magnetic resonance imaging(MRI)scans done for ALS patients who do not receive stem cells are part of routine clinical studies and therefore subjects will not be billed."
            }
        ], 
        "brief_summary": {
            "textblock": "Study the cervical spinal cord and brain over time to assess changes and differences in\n      subjects with amyotrophic lateral sclerosis."
        }, 
        "brief_title": "Therapeutic Imaging Biomarkers for Amyotrophic Lateral Sclerosis", 
        "completion_date": {
            "#text": "December 2019", 
            "@type": "Anticipated"
        }, 
        "condition": "Amyotrophic Lateral Sclerosis", 
        "condition_browse": {
            "mesh_term": [
                "Amyotrophic Lateral Sclerosis", 
                "Sclerosis", 
                "Motor Neuron Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "Investigators will study cervical spinal cord chemical concentrations and cervical spinal\n      cord and brain microstructure in amyotrophic lateral sclerosis(ALS) patients who have had a\n      stem cell transplant compared to ALS patients who have not had a stem cell transplant.\n      Investigators intend to determine cervical spinal cord chemical concentrations and cervical\n      spinal cord and brain microstructure in amyotrophic lateral sclerosis(ALS) patients who have\n      had a stem cell transplant and compare these to corresponding measures in amyotrophic\n      lateral sclerosis(ALS) patients who have not had a stem cell transplant."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. 18 years of age or older\n\n          2. Subjects with amyotrophic lateral sclerosis -\n\n        Exclusion Criteria:\n\n          1. Do not have opportunistic central nervous system infection\n\n          2. Do not have a history of head injury\n\n          3. Do not have cerebrovascular disease\n\n          4. Do not have a contraindication for MRI(e.g. cardiac pacemaker, ferromagnetic or\n             metallic implants).\n\n          5. Must not be pregnant -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "17", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02058732", 
            "org_study_id": "HUM00078370"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "ALS patients receivng stem cells", 
                    "ALS patients not receiving stem cells"
                ], 
                "description": "Subjects will have an MRI that lasts approximately 60 minutes at the same time points as during the stem cell study schedule; once before the stem cell surgery, and again at 1, 6, 12, 18, 24, 36, and 48 months after receiving stem cells.  This magnetic resonance imaging(MRI)scan will be of the cervical spine and brain.", 
                "intervention_name": "ALS Patients receiving stem cells", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": [
                    "ALS patients receivng stem cells", 
                    "ALS patients not receiving stem cells"
                ], 
                "description": "Amyotrophic lateral sclerosis patients who will not receive stem cells will have a magnetic resonance imaging(MRI)scan.  This scan will be of the cervical spine and brain.  The scan will last approximately 60 minutes.  This MRI scan will be repeated at both 6 and 12 months.  Subjects will also complete a clinical examination that takes about 30 minutes for each MRI scan.", 
                "intervention_name": "ALS patients not receiving stem cells", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 6, 2014", 
        "location": {
            "contact": {
                "last_name": "Bradley Foerster, M.D.", 
                "phone": "734-615-3586"
            }, 
            "facility": {
                "address": {
                    "city": "Ann Arbor", 
                    "country": "United States", 
                    "state": "Michigan", 
                    "zip": "48109"
                }, 
                "name": "University of Michigan Hospital"
            }, 
            "investigator": {
                "last_name": "Bradley Foerster, M.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Therapeutic Imaging Biomarkers for Amyotrophic Lateral Sclerosis", 
        "overall_contact": {
            "last_name": "Bradley Foerster, M.D.", 
            "phone": "734-615-3586"
        }, 
        "overall_contact_backup": {
            "email": "ladonna@umich.edu", 
            "last_name": "Ladonna Austin, CCRC", 
            "phone": "734-936-8275"
        }, 
        "overall_official": {
            "affiliation": "University of Michigan Hospital", 
            "last_name": "Bradley Foerster, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "1.  The longitudinal changes in spinal cord metabolites in amyotrophic lateral sclerosis(ALS) stem cell treated patients will be compared to amyotrophic lateral sclerosis(ALS) non-treated patients using magnetic resonance spectroscopy.  Investigators hypothesize that amyotrophic lateral sclerosis(ALS) stem cell treated patients will demonstrate attenuated rates of decline in the levels of N-acetylaspartate(NAA), a measure of neuronal integrity, in the cervical spinal cord than amyotrophic lateral sclerosis(ALS) non-treated patients.", 
            "measure": "Changes in spinal cord metabolites in treated ALS subjects and nontreated ALS subjects.", 
            "safety_issue": "No", 
            "time_frame": "5  years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02058732"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Michigan", 
            "investigator_full_name": "Bradley Foerster M.D.", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Michigan", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Michigan", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}